24 May 2013
Keywords: epistent, update, confirms, reopro, role, stenting, six-month
Article | 01 September 1998
Six-month follow-up data from the first trial of glycoprotein IIb/IIIareceptor blockade in coronary stenting - EPISTENT - have confirmed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 1998
3 September 1998
23 May 2013
© 2013 thepharmaletter.com